Literature DB >> 23143454

Topical linezolid for refractory bilateral Mycobacterium chelonae post-laser-assisted in situ keratomileusis keratitis.

Rosa Dolz-Marco, Patricia Udaondo, Roberto Gallego-Pinazo, J Maria Millán, Manuel Díaz-Llopis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143454     DOI: 10.1001/archophthalmol.2012.1495

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  5 in total

1.  Management of nontuberculous mycobacterial infections of the eye and orbit: A retrospective case series.

Authors:  Alice Y Kim; Alexander S Davis; Annie Moreau; Douglas A Drevets; Dante P Melendez
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-21

Review 2.  Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature.

Authors:  Wajiha J Kheir; Huda Sheheitli; Maamoun Abdul Fattah; Rola N Hamam
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

3.  Mycobacterium chelonae in a tectonic corneal graft.

Authors:  Haziq Raees Chowdhury; Oliver Comyn; Gill Jones; Mayank A Nanavaty
Journal:  Oman J Ophthalmol       Date:  2016 Sep-Dec

4.  Minimum inhibitory concentrations and resistance for selected antimicrobial agents (including imipenem, linezolid and tigecycline) of bacteria obtained from eye infections.

Authors:  Virgilio Galvis; Alejandro Tello; Walter Sánchez; Paul Camacho; Donaldo Villarreal; Diana García
Journal:  Rom J Ophthalmol       Date:  2020 Jul-Sep

5.  Successful Treatment of Mycobacterium chelonae Keratitis Within a Corneal Transplant Using Intrastromal Amikacin Injections-A Case Report Demonstrating the Fundamental Principles and Challenges of Infective Keratitis Management and Novel Therapeutic Approaches.

Authors:  Nancy Louisa Merridew; Ravinder Singh Phagura; Edward Anderson; Louise Anne Cooley; Graeme Alfred Pollock; Belinda McEwan; Paul James McCartney; Mohamad-Ali Trad
Journal:  Open Forum Infect Dis       Date:  2019-07-22       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.